Ending Discrimination in COVID–19 Treatments Act
Summary
Ending Discrimination in COVID-19 Treatments Act This bill prohibits consideration of certain factors, including vaccination status, in decisions about an individual's access to federally provided monoclonal antibody therapies to treat COVID-19. As a condition of receiving the therapies from the federal government, states must ensure that providers do not consider specified demographic characteristics, veteran status, or political ideology or speech when determining a patient's eligibility for such therapies.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2022
Committee Review
Floor Vote
President
Introduced Mar 31, 2022
Last action Mar 31, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Mar 31, 2022
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Mar 31, 2022
Introduced
Introduced in Senate
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Ted Cruz
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 3974
Scope: US
Hi! I can help you understand S 3974. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline